BioSpherix Awarded Grant to Establish Center for Cytocentric® Technology in Winston-Salem

BioSpherix has been selected to receive a prestigious grant from the Piedmont Triad Regenerative Medicine Engine (PTRME), funded by the National Science Foundation (NSF). This Ecosystem Building Grant, announced on December 4, 2024, will support BioSpherix in establishing the BioSpherix "Center for Cytocentric Technology" at PTRME’s Winston-Salem facility.

The funding will play a pivotal role in advancing regenerative medicine in the Piedmont Triad region by enabling pioneering companies to address key challenges in the field. For BioSpherix, the center will leverage their cutting-edge Xvivo System®, a revolutionary technology designed to improve cell culture efficiency and reproducibility, streamline manufacturing, and facilitate the training of the next generation of talent in regenerative medicine. The BioSpherix "Center for Cytocentric Technology" will also be instrumental in enhancing the scalability of regenerative medicine manufacturing.

From the BioSpherix team: "We are extremely proud to have been selected as a recipient of this grant and grateful to the Piedmont Triad Regenerative Medicine Engine and the National Science Foundation for this incredible opportunity!"